TrialJournal of diabetes science and technology2011

Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.

Andreas Pfützner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.